Loading...

McKesson Corporation

MCKNYSE
Healthcare
Medical - Distribution
$711.82
$1.63(0.23%)

McKesson Corporation (MCK) Stock Overview

Explore McKesson Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 73.8/100

Key Financials

Market Cap88.9B
P/E Ratio27.06
EPS (TTM)$25.71
ROE-1.33%
Fundamental Analysis

AI Price Forecasts

1 Week$718.31
1 Month$717.95
3 Months$685.91
1 Year Target$733.59

MCK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of McKesson Corporation (MCK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 46.69, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $733.59.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 27.06 and a market capitalization of 88.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;